Data / Form D filings / AcuFocus, Inc.
AcuFocus, Inc.: Form D filings
AcuFocus, Inc., a biotechnology company in Irvine, CA, filed 9 Form D notices with the SEC between 2011 and 2018. The latest, on August 20, 2018, reports $24 million sold of a $26 million offering to 15 investors.
Find out what AcuFocus, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 32 DISCOVERY, SUITE 200, Irvine, CA, 92618
- Phone
- (949) 585-9511
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1165260
The full lists. Form D filings in California: 5,891 rows, $138.91, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 20, 2018 | New notice | $26,000,000 | $23,974,000 | $2,026,000 | 15 | Aug 8, 2018 | sec.gov |
| Oct 5, 2016 | New notice | $74,924,639 | $74,924,639 | $0 | 19 | Sep 23, 2016 | sec.gov |
| Aug 24, 2016 | New notice | $2,000,000 | $2,000,000 | $0 | 15 | Aug 10, 2016 | sec.gov |
| Jul 8, 2016 | New notice | $2,500,000 | $1,866,084 | $633,916 | 14 | Jun 24, 2016 | sec.gov |
| May 11, 2016 | Amendment | $6,000,000 | $5,800,000 | $200,000 | 17 | Mar 17, 2016 | sec.gov |
| Mar 30, 2016 | New notice | $5,000,000 | $4,050,405 | $949,595 | 16 | Mar 17, 2016 | sec.gov |
| Nov 24, 2015 | New notice | $5,000,000 | $1,998,474 | $3,001,526 | 11 | Nov 10, 2015 | sec.gov |
| Sep 12, 2014 | New notice | $15,695,083 | $15,240,189 | $454,894 | 20 | Aug 29, 2014 | sec.gov |
| Dec 28, 2011 | New notice | $41,868,522 | $41,868,522 | $0 | 23 | Nov 7, 2011 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Ali J. Satvat | Director | |
| Gloria Sefton | Executive Officer | |
| Conrad Wang | Director | |
| Richard L. Lindstrom, M.D. | Director | |
| William J. Link | Director | |
| Buzz Benson | Director | |
| Arjun J. Arora | Director | |
| Greg Madden | Director | |
| Alan Waterhouse | Executive Officer, Director |
Other biotechnology companies in California that filed recently
- CARI Health, Inc. $280,000 · Nov 6, 2026
- Ausel, Inc. $120,000 · Nov 4, 2026
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
Every Form D from the week of Aug 20, 2018 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what AcuFocus, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.